Rchr
J-GLOBAL ID:201501021162619776   Update date: Apr. 14, 2024

Nakai Takuya

ナカイ タクヤ | Nakai Takuya
Affiliation and department:
Homepage URL  (1): https://kaken.nii.ac.jp/d/r/60227725.ja.html
Research field  (2): Digestive surgery ,  General surgery, pediatric surgery
Research keywords  (19): DNA マイクロアレイ ,  小腸移腸 ,  グルタミン ,  NK activity ,  小腸移植 ,  HVGD ,  rejection ,  CTL activity ,  ラット小腸移植 ,  NKT cell ,  rat ,  GVHD ,  Chimerism ,  FK506 ,  肝再生 ,  アメリカ ,  肝癌ワクチン治療 ,  ヨーロッパ ,  免疫治療
Research theme for competitive and other funds  (3):
  • 2011 - 2013 Peptide-cocktail vaccination for hepatocellular carcinoma
  • 1999 - 2001 Mechanism of liver regeneration from the viewpoints of cytotoxis activity and cell growth factors, and development of a method for enhancement of liver regeneration using glutamine
  • 1996 - 1997 Immunosuppressive mechanism by FK506 following small bowel trasplantation in rats-analysing for immunologic factors-
Papers (111):
  • Terufumi Yoshida, Kazuko Sakai, Masaki Kaibori, Mitsuaki Ishida, Shogo Tanaka, Shoji Kubo, Takuya Nakai, Marco De Velasco, Hideyuki Matsushima, Koji Tsuta, et al. Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma. Oncology Letters. 2024. 27. 3
  • Masato Ota, Koji Komeda, Hiroya Osaka Iida, Masaki Ueno, Hisashi Kosaka, Takeo Nomi, Shogo Tanaka, Takuya Nakai, Daisuke Hokutou, Masataka Matsumoto, et al. ASO Visual Abstract: The Prognostic Value of Preoperative Serum Markers and Risk Classification for Patients with Hepatocellular Carcinoma. Annals of surgical oncology. 2023. 30. 5. 2818-2819
  • Masato Ota, Koji Komeda, Hiroya Iida, Masaki Ueno, Hisashi Kosaka, Takeo Nomi, Shogo Tanaka, Takuya Nakai, Daisuke Hokutou, Masataka Matsumoto, et al. The Prognostic Value of Preoperative Serum Markers and Risk Classification in Patients with Hepatocellular Carcinoma. Annals of surgical oncology. 2023. 30. 5. 2807-2815
  • Shumpei Satoi, Yutaka Kimura, Rie Shimizu, Masataka Matsumoto, Kohei Kawaguchi, Yuta Yoshida, Takaaki Murase, Keiko Kamei, Ippei Matsumoto, Takuya Nakai, et al. Gastrectomy reduces pancreatic secretory function via pancreatic atrophy. Surgery today. 2023
  • 田中 肖吾, 飯田 洋也, 上野 昌樹, 米田 浩二, 北東 大督, 中居 卓也, 小坂 久, 生駒 久視, 野田 剛広, 新川 寛二, et al. 80歳以上の高齢者に対する肝切除後治療成績 術後1年後に自立生活を困難にする要因の解析. 日本臨床外科学会雑誌. 2022. 83. 増刊. S231-S231
more...
MISC (212):
  • Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, Naoshi Nishida, Hiroshi Ida, Yasunori Minami, Takuya Nakai, Hiroshi Wada, Shoji Kubo, Kazuyoshi Ohkawa, et al. Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 4
  • Masatoshi Kudo, Kazuomi Ueshima, Shin Nakahira, Naoshi Nishida, Hiroshi Ida, Yasunori Minami, Takuya Nakai, Hiroshi Wada, Shoji Kubo, Kazuyoshi Ohkawa, et al. Adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 15
  • 吉田雄太, 松本逸平, 川口晃平, 松本正孝, 李東河, 村瀬貴昭, 亀井敬子, 里井俊平, 武部敦志, 中居卓也, et al. 当院における局所進行切除不能膵癌に対するconversion surgeryの短期・長期成績の検討. 膵臓(Web). 2021. 36. 3
  • 松本正孝, 松本逸平, 吉田雄太, 山雄健太郎, 川口晃平, 村瀬貴昭, 大本俊介, 亀井敬子, 里井俊平, 竹中完, et al. Disconnected pancreatic duct syndromeの外科治療症例の検討. 膵臓(Web). 2020. 35. 3
  • 田中 肖吾, 上野 昌樹, 飯田 洋也, 海堀 昌樹, 野見 武男, 廣川 文鋭, 生駒 久視, 中居 卓也, 江口 英利, 久保 正二. Frailな患者に対する消化器外科手術 術前フレイル判定は肝切除後の加齢に関連した合併症の予測因子になりうる 多施設前向き研究による検討. 日本消化器外科学会総会. 2019. 74回. WS18-8
more...
Professional career (1):
  • Doctor of Medicine (Kindai University)
Work history (2):
  • 2019/10 - 現在 Kindai University
  • 2011 - 2019/09 Kindai University Faculty of Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page